instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the outcome of reaction 'Protein urine present'? | Low-Vacuum Scanning Electron Microscopy to Assess Histopathological Resolution of Class V Lupus Nephritis: A Case Report.
Lupus nephritis (LN) is most frequently associated with poor outcomes in patients with systemic lupus erythematosus (SLE). LN manifests as histopathological changes in the kidney caused by immune co... | Recovering | ReactionOutcome | CC BY-NC | 33708798 | 19,404,881 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myelosuppression'. | Real-world experience with pembrolizumab in patients with advanced soft tissue sarcoma.
The goal of this study was to retrospectively analyze the efficacy and safety of pembrolizumab in the real-world treatment of soft tissue sarcoma (STS).
We analyzed 38 patients who suffered from STS and received pembrolizumab treatm... | PAZOPANIB, PEMBROLIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 33708966 | 19,494,768 | 2021-02 |
What was the dosage of drug 'PAZOPANIB'? | Real-world experience with pembrolizumab in patients with advanced soft tissue sarcoma.
The goal of this study was to retrospectively analyze the efficacy and safety of pembrolizumab in the real-world treatment of soft tissue sarcoma (STS).
We analyzed 38 patients who suffered from STS and received pembrolizumab treatm... | UNK, CYCLIC (2 CYCLES) | DrugDosageText | CC BY-NC-ND | 33708966 | 19,494,768 | 2021-02 |
What was the dosage of drug 'PEMBROLIZUMAB'? | Real-world experience with pembrolizumab in patients with advanced soft tissue sarcoma.
The goal of this study was to retrospectively analyze the efficacy and safety of pembrolizumab in the real-world treatment of soft tissue sarcoma (STS).
We analyzed 38 patients who suffered from STS and received pembrolizumab treatm... | UNK, CYCLIC (2 CYCLES) | DrugDosageText | CC BY-NC-ND | 33708966 | 19,494,768 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood lactic acid increased'. | Capecitabine-mediated heart failure in colorectal cancer: a case series.
Capecitabine is a pyrimidine antimetabolite that inhibits thymidylate synthase and is commonly used in the treatment of colorectal cancer. Adverse cardiac side effects are reported in 1-18% of patients receiving Capecitabine. The most commonly pro... | CAPECITABINE, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 33709051 | 19,507,644 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac failure acute'. | Capecitabine-mediated heart failure in colorectal cancer: a case series.
Capecitabine is a pyrimidine antimetabolite that inhibits thymidylate synthase and is commonly used in the treatment of colorectal cancer. Adverse cardiac side effects are reported in 1-18% of patients receiving Capecitabine. The most commonly pro... | CAPECITABINE, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 33709051 | 19,507,644 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac failure'. | Capecitabine-mediated heart failure in colorectal cancer: a case series.
Capecitabine is a pyrimidine antimetabolite that inhibits thymidylate synthase and is commonly used in the treatment of colorectal cancer. Adverse cardiac side effects are reported in 1-18% of patients receiving Capecitabine. The most commonly pro... | CAPECITABINE, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 33709051 | 19,061,134 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiogenic shock'. | Capecitabine-mediated heart failure in colorectal cancer: a case series.
Capecitabine is a pyrimidine antimetabolite that inhibits thymidylate synthase and is commonly used in the treatment of colorectal cancer. Adverse cardiac side effects are reported in 1-18% of patients receiving Capecitabine. The most commonly pro... | CAPECITABINE, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 33709051 | 19,061,134 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiomyopathy'. | Capecitabine-mediated heart failure in colorectal cancer: a case series.
Capecitabine is a pyrimidine antimetabolite that inhibits thymidylate synthase and is commonly used in the treatment of colorectal cancer. Adverse cardiac side effects are reported in 1-18% of patients receiving Capecitabine. The most commonly pro... | CAPECITABINE, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 33709051 | 19,507,644 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiotoxicity'. | Capecitabine-mediated heart failure in colorectal cancer: a case series.
Capecitabine is a pyrimidine antimetabolite that inhibits thymidylate synthase and is commonly used in the treatment of colorectal cancer. Adverse cardiac side effects are reported in 1-18% of patients receiving Capecitabine. The most commonly pro... | CAPECITABINE, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 33709051 | 19,507,644 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mitral valve incompetence'. | Capecitabine-mediated heart failure in colorectal cancer: a case series.
Capecitabine is a pyrimidine antimetabolite that inhibits thymidylate synthase and is commonly used in the treatment of colorectal cancer. Adverse cardiac side effects are reported in 1-18% of patients receiving Capecitabine. The most commonly pro... | CAPECITABINE, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 33709051 | 19,061,134 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nausea'. | Capecitabine-mediated heart failure in colorectal cancer: a case series.
Capecitabine is a pyrimidine antimetabolite that inhibits thymidylate synthase and is commonly used in the treatment of colorectal cancer. Adverse cardiac side effects are reported in 1-18% of patients receiving Capecitabine. The most commonly pro... | CAPECITABINE, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 33709051 | 19,077,698 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pulmonary oedema'. | Capecitabine-mediated heart failure in colorectal cancer: a case series.
Capecitabine is a pyrimidine antimetabolite that inhibits thymidylate synthase and is commonly used in the treatment of colorectal cancer. Adverse cardiac side effects are reported in 1-18% of patients receiving Capecitabine. The most commonly pro... | CAPECITABINE, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 33709051 | 19,061,134 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vomiting'. | Capecitabine-mediated heart failure in colorectal cancer: a case series.
Capecitabine is a pyrimidine antimetabolite that inhibits thymidylate synthase and is commonly used in the treatment of colorectal cancer. Adverse cardiac side effects are reported in 1-18% of patients receiving Capecitabine. The most commonly pro... | CAPECITABINE, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 33709051 | 19,077,698 | 2021-03 |
What was the administration route of drug 'CAPECITABINE'? | Capecitabine-mediated heart failure in colorectal cancer: a case series.
Capecitabine is a pyrimidine antimetabolite that inhibits thymidylate synthase and is commonly used in the treatment of colorectal cancer. Adverse cardiac side effects are reported in 1-18% of patients receiving Capecitabine. The most commonly pro... | Oral | DrugAdministrationRoute | CC BY-NC | 33709051 | 19,507,644 | 2021-03 |
What was the outcome of reaction 'Cardiac failure acute'? | Capecitabine-mediated heart failure in colorectal cancer: a case series.
Capecitabine is a pyrimidine antimetabolite that inhibits thymidylate synthase and is commonly used in the treatment of colorectal cancer. Adverse cardiac side effects are reported in 1-18% of patients receiving Capecitabine. The most commonly pro... | Recovered | ReactionOutcome | CC BY-NC | 33709051 | 19,507,644 | 2021-03 |
What was the outcome of reaction 'Cardiac failure'? | Capecitabine-mediated heart failure in colorectal cancer: a case series.
Capecitabine is a pyrimidine antimetabolite that inhibits thymidylate synthase and is commonly used in the treatment of colorectal cancer. Adverse cardiac side effects are reported in 1-18% of patients receiving Capecitabine. The most commonly pro... | Recovered | ReactionOutcome | CC BY-NC | 33709051 | 19,061,134 | 2021-03 |
What was the outcome of reaction 'Cardiogenic shock'? | Capecitabine-mediated heart failure in colorectal cancer: a case series.
Capecitabine is a pyrimidine antimetabolite that inhibits thymidylate synthase and is commonly used in the treatment of colorectal cancer. Adverse cardiac side effects are reported in 1-18% of patients receiving Capecitabine. The most commonly pro... | Recovered | ReactionOutcome | CC BY-NC | 33709051 | 19,061,134 | 2021-03 |
What was the outcome of reaction 'Cardiomyopathy'? | Capecitabine-mediated heart failure in colorectal cancer: a case series.
Capecitabine is a pyrimidine antimetabolite that inhibits thymidylate synthase and is commonly used in the treatment of colorectal cancer. Adverse cardiac side effects are reported in 1-18% of patients receiving Capecitabine. The most commonly pro... | Recovered | ReactionOutcome | CC BY-NC | 33709051 | 19,507,644 | 2021-03 |
What was the outcome of reaction 'Cardiotoxicity'? | Capecitabine-mediated heart failure in colorectal cancer: a case series.
Capecitabine is a pyrimidine antimetabolite that inhibits thymidylate synthase and is commonly used in the treatment of colorectal cancer. Adverse cardiac side effects are reported in 1-18% of patients receiving Capecitabine. The most commonly pro... | Recovered | ReactionOutcome | CC BY-NC | 33709051 | 19,507,644 | 2021-03 |
What was the outcome of reaction 'Mitral valve incompetence'? | Capecitabine-mediated heart failure in colorectal cancer: a case series.
Capecitabine is a pyrimidine antimetabolite that inhibits thymidylate synthase and is commonly used in the treatment of colorectal cancer. Adverse cardiac side effects are reported in 1-18% of patients receiving Capecitabine. The most commonly pro... | Recovered | ReactionOutcome | CC BY-NC | 33709051 | 19,061,134 | 2021-03 |
What was the outcome of reaction 'Nausea'? | Capecitabine-mediated heart failure in colorectal cancer: a case series.
Capecitabine is a pyrimidine antimetabolite that inhibits thymidylate synthase and is commonly used in the treatment of colorectal cancer. Adverse cardiac side effects are reported in 1-18% of patients receiving Capecitabine. The most commonly pro... | Recovered | ReactionOutcome | CC BY-NC | 33709051 | 19,077,698 | 2021-03 |
What was the outcome of reaction 'Vomiting'? | Capecitabine-mediated heart failure in colorectal cancer: a case series.
Capecitabine is a pyrimidine antimetabolite that inhibits thymidylate synthase and is commonly used in the treatment of colorectal cancer. Adverse cardiac side effects are reported in 1-18% of patients receiving Capecitabine. The most commonly pro... | Recovered | ReactionOutcome | CC BY-NC | 33709051 | 19,077,698 | 2021-03 |
What was the administration route of drug 'LACOSAMIDE'? | Intravenous immunoglobulin response in new-onset refractory status epilepticus (NORSE) COVID-19 adult patients.
Neurological manifestations may be common in COVID-19 patients. They may include several syndromes, such as a suggested autoimmune abnormal response, which may result in encephalitis and new-onset refractory ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33709220 | 20,076,567 | 2021-10 |
What was the administration route of drug 'LEVETIRACETAM'? | Intravenous immunoglobulin response in new-onset refractory status epilepticus (NORSE) COVID-19 adult patients.
Neurological manifestations may be common in COVID-19 patients. They may include several syndromes, such as a suggested autoimmune abnormal response, which may result in encephalitis and new-onset refractory ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33709220 | 20,076,567 | 2021-10 |
What was the administration route of drug 'PHENYTOIN'? | Intravenous immunoglobulin response in new-onset refractory status epilepticus (NORSE) COVID-19 adult patients.
Neurological manifestations may be common in COVID-19 patients. They may include several syndromes, such as a suggested autoimmune abnormal response, which may result in encephalitis and new-onset refractory ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33709220 | 20,076,567 | 2021-10 |
What was the administration route of drug 'VALPROIC ACID'? | Intravenous immunoglobulin response in new-onset refractory status epilepticus (NORSE) COVID-19 adult patients.
Neurological manifestations may be common in COVID-19 patients. They may include several syndromes, such as a suggested autoimmune abnormal response, which may result in encephalitis and new-onset refractory ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33709220 | 20,076,567 | 2021-10 |
What was the dosage of drug 'PHENYTOIN'? | Intravenous immunoglobulin response in new-onset refractory status epilepticus (NORSE) COVID-19 adult patients.
Neurological manifestations may be common in COVID-19 patients. They may include several syndromes, such as a suggested autoimmune abnormal response, which may result in encephalitis and new-onset refractory ... | 18 MG/KG | DrugDosageText | CC BY | 33709220 | 20,076,567 | 2021-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug resistance'. | Targeting FGFR in non-small cell lung cancer: implications from the landscape of clinically actionable aberrations of FGFR kinases.
OBJECTIVE
Dysfunction in fibroblast growth factor receptor (FGFR) signaling has been reported in diverse cancer types, including non-small cell lung cancer (NSCLC). The frequency of FGFR a... | ERLOTINIB, OSIMERTINIB | DrugsGivenReaction | CC BY | 33710807 | 20,964,792 | 2021-03-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Long QT syndrome'. | Syncope due to non-sustained episodes of Torsade de Pointes associated to androgen-deprivation therapy use: a case presentation.
Abiraterone is a medication frequently used for metastatic castrate-resistant prostate cancer. We report a case of non-sustained episodes of TdP associated with severe hypokalemia due to andr... | ABIRATERONE ACETATE, LEUPROLIDE, LOSARTAN, METOPROLOL SUCCINATE | DrugsGivenReaction | CC BY | 33711933 | 19,896,834 | 2021-03-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ventricular extrasystoles'. | Syncope due to non-sustained episodes of Torsade de Pointes associated to androgen-deprivation therapy use: a case presentation.
Abiraterone is a medication frequently used for metastatic castrate-resistant prostate cancer. We report a case of non-sustained episodes of TdP associated with severe hypokalemia due to andr... | ABIRATERONE ACETATE, LEUPROLIDE ACETATE, LOSARTAN, METOPROLOL SUCCINATE | DrugsGivenReaction | CC BY | 33711933 | 19,098,635 | 2021-03-12 |
What was the outcome of reaction 'Cardiomyopathy'? | Syncope due to non-sustained episodes of Torsade de Pointes associated to androgen-deprivation therapy use: a case presentation.
Abiraterone is a medication frequently used for metastatic castrate-resistant prostate cancer. We report a case of non-sustained episodes of TdP associated with severe hypokalemia due to andr... | Recovered | ReactionOutcome | CC BY | 33711933 | 19,896,834 | 2021-03-12 |
What was the outcome of reaction 'Hypokalaemia'? | Syncope due to non-sustained episodes of Torsade de Pointes associated to androgen-deprivation therapy use: a case presentation.
Abiraterone is a medication frequently used for metastatic castrate-resistant prostate cancer. We report a case of non-sustained episodes of TdP associated with severe hypokalemia due to andr... | Recovered | ReactionOutcome | CC BY | 33711933 | 19,896,834 | 2021-03-12 |
What was the outcome of reaction 'Hypomagnesaemia'? | Syncope due to non-sustained episodes of Torsade de Pointes associated to androgen-deprivation therapy use: a case presentation.
Abiraterone is a medication frequently used for metastatic castrate-resistant prostate cancer. We report a case of non-sustained episodes of TdP associated with severe hypokalemia due to andr... | Recovered | ReactionOutcome | CC BY | 33711933 | 19,896,834 | 2021-03-12 |
What was the outcome of reaction 'Long QT syndrome'? | Syncope due to non-sustained episodes of Torsade de Pointes associated to androgen-deprivation therapy use: a case presentation.
Abiraterone is a medication frequently used for metastatic castrate-resistant prostate cancer. We report a case of non-sustained episodes of TdP associated with severe hypokalemia due to andr... | Recovered | ReactionOutcome | CC BY | 33711933 | 19,896,834 | 2021-03-12 |
What was the outcome of reaction 'Torsade de pointes'? | Syncope due to non-sustained episodes of Torsade de Pointes associated to androgen-deprivation therapy use: a case presentation.
Abiraterone is a medication frequently used for metastatic castrate-resistant prostate cancer. We report a case of non-sustained episodes of TdP associated with severe hypokalemia due to andr... | Recovered | ReactionOutcome | CC BY | 33711933 | 19,896,834 | 2021-03-12 |
What was the outcome of reaction 'Ventricular extrasystoles'? | Syncope due to non-sustained episodes of Torsade de Pointes associated to androgen-deprivation therapy use: a case presentation.
Abiraterone is a medication frequently used for metastatic castrate-resistant prostate cancer. We report a case of non-sustained episodes of TdP associated with severe hypokalemia due to andr... | Recovered | ReactionOutcome | CC BY | 33711933 | 19,098,635 | 2021-03-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Epirubicin-induced Kounis syndrome.
Kounis syndrome is an acute coronary syndrome that appears in the setting of anaphylactic reaction or hypersensitivity. Many drugs and environmental exposures have been identified as potential offenders, and diagnosis and treatment can be challenging.
A 62-year-old man with recurr... | EPIRUBICIN HYDROCHLORIDE, SODIUM CHLORIDE | DrugsGivenReaction | CC BY | 33711934 | 19,074,491 | 2021-03-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use issue'. | Epirubicin-induced Kounis syndrome.
Kounis syndrome is an acute coronary syndrome that appears in the setting of anaphylactic reaction or hypersensitivity. Many drugs and environmental exposures have been identified as potential offenders, and diagnosis and treatment can be challenging.
A 62-year-old man with recurr... | EPIRUBICIN HYDROCHLORIDE, SODIUM CHLORIDE | DrugsGivenReaction | CC BY | 33711934 | 19,074,491 | 2021-03-12 |
What was the administration route of drug 'EPIRUBICIN HYDROCHLORIDE'? | Epirubicin-induced Kounis syndrome.
Kounis syndrome is an acute coronary syndrome that appears in the setting of anaphylactic reaction or hypersensitivity. Many drugs and environmental exposures have been identified as potential offenders, and diagnosis and treatment can be challenging.
A 62-year-old man with recurr... | Intra-arterial | DrugAdministrationRoute | CC BY | 33711934 | 19,074,491 | 2021-03-12 |
What was the administration route of drug 'SODIUM CHLORIDE'? | Epirubicin-induced Kounis syndrome.
Kounis syndrome is an acute coronary syndrome that appears in the setting of anaphylactic reaction or hypersensitivity. Many drugs and environmental exposures have been identified as potential offenders, and diagnosis and treatment can be challenging.
A 62-year-old man with recurr... | Intra-arterial | DrugAdministrationRoute | CC BY | 33711934 | 19,074,491 | 2021-03-12 |
What was the dosage of drug 'SODIUM CHLORIDE'? | Epirubicin-induced Kounis syndrome.
Kounis syndrome is an acute coronary syndrome that appears in the setting of anaphylactic reaction or hypersensitivity. Many drugs and environmental exposures have been identified as potential offenders, and diagnosis and treatment can be challenging.
A 62-year-old man with recurr... | 50 ML | DrugDosageText | CC BY | 33711934 | 19,074,491 | 2021-03-12 |
What was the outcome of reaction 'Kounis syndrome'? | Epirubicin-induced Kounis syndrome.
Kounis syndrome is an acute coronary syndrome that appears in the setting of anaphylactic reaction or hypersensitivity. Many drugs and environmental exposures have been identified as potential offenders, and diagnosis and treatment can be challenging.
A 62-year-old man with recurr... | Recovered | ReactionOutcome | CC BY | 33711934 | 19,074,491 | 2021-03-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Actinomycosis'. | Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis.
BACKGROUND
Some patients with systemic juvenile idiopathic arthritis (SJIA) and severe, refractory disease achieved remission through intensive immunosuppressive treatment followed by ... | ALEMTUZUMAB, BUSULFAN, CYCLOPHOSPHAMIDE, CYCLOSPORINE, FLUDARABINE PHOSPHATE, INDOMETHACIN, INFLIXIMAB, METHOTREXATE, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, PREDNISOLONE, RITUXIMAB, THALIDOMIDE | DrugsGivenReaction | CC BY | 33712044 | 19,154,451 | 2021-03-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute graft versus host disease in skin'. | Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis.
BACKGROUND
Some patients with systemic juvenile idiopathic arthritis (SJIA) and severe, refractory disease achieved remission through intensive immunosuppressive treatment followed by ... | ADALIMUMAB, ALEMTUZUMAB, ANAKINRA, BUSULFAN, CANAKINUMAB, CYCLOPHOSPHAMIDE, CYCLOSPORINE, FLUDARABINE PHOSPHATE, INDOMETHACIN, INFLIXIMAB, METHOTREXATE, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, PREDNISOLONE, RITUXIMAB, THALIDOMIDE, TOCILIZUMAB | DrugsGivenReaction | CC BY | 33712044 | 19,100,589 | 2021-03-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Adrenal insufficiency'. | Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis.
BACKGROUND
Some patients with systemic juvenile idiopathic arthritis (SJIA) and severe, refractory disease achieved remission through intensive immunosuppressive treatment followed by ... | ALEMTUZUMAB, BUSULFAN, CYCLOPHOSPHAMIDE, CYCLOSPORINE, FLUDARABINE PHOSPHATE, INDOMETHACIN, INFLIXIMAB, METHOTREXATE, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, PREDNISOLONE, RITUXIMAB, THALIDOMIDE | DrugsGivenReaction | CC BY | 33712044 | 19,154,451 | 2021-03-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Arthritis'. | Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis.
BACKGROUND
Some patients with systemic juvenile idiopathic arthritis (SJIA) and severe, refractory disease achieved remission through intensive immunosuppressive treatment followed by ... | ADALIMUMAB, ALEMTUZUMAB, ANAKINRA, BUSULFAN, CANAKINUMAB, CYCLOPHOSPHAMIDE, CYCLOSPORINE, FLUDARABINE PHOSPHATE, INDOMETHACIN, INFLIXIMAB, METHOTREXATE, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, PREDNISOLONE, RITUXIMAB, THALIDOMIDE, TOCILIZUMAB | DrugsGivenReaction | CC BY | 33712044 | 19,100,589 | 2021-03-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Arthropathy'. | Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis.
BACKGROUND
Some patients with systemic juvenile idiopathic arthritis (SJIA) and severe, refractory disease achieved remission through intensive immunosuppressive treatment followed by ... | ALEMTUZUMAB, BUSULFAN, CYCLOPHOSPHAMIDE, CYCLOSPORINE, FLUDARABINE PHOSPHATE, INDOMETHACIN, INFLIXIMAB, METHOTREXATE, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, PREDNISOLONE, RITUXIMAB, THALIDOMIDE | DrugsGivenReaction | CC BY | 33712044 | 19,154,451 | 2021-03-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bronchiolitis'. | Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis.
BACKGROUND
Some patients with systemic juvenile idiopathic arthritis (SJIA) and severe, refractory disease achieved remission through intensive immunosuppressive treatment followed by ... | ACYCLOVIR, ADALIMUMAB, ALEMTUZUMAB, ANAKINRA, BUSULFAN, CANAKINUMAB, CYCLOPHOSPHAMIDE, CYCLOSPORINE, FLUDARABINE PHOSPHATE, HYDROCORTISONE, INDOMETHACIN, INFLIXIMAB, METHOTREXATE, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, PREDNISOLONE, RITUXIMAB, THALIDOMIDE, TOCILIZUMAB | DrugsGivenReaction | CC BY | 33712044 | 18,668,075 | 2021-03-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis.
BACKGROUND
Some patients with systemic juvenile idiopathic arthritis (SJIA) and severe, refractory disease achieved remission through intensive immunosuppressive treatment followed by ... | ADALIMUMAB, ALEMTUZUMAB, ANAKINRA, BUSULFAN, CANAKINUMAB, CYCLOPHOSPHAMIDE, CYCLOSPORINE, FLUDARABINE PHOSPHATE, INDOMETHACIN, INFLIXIMAB, METHOTREXATE, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, PREDNISOLONE, RITUXIMAB, THALIDOMIDE, TOCILIZUMAB | DrugsGivenReaction | CC BY | 33712044 | 19,100,589 | 2021-03-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis.
BACKGROUND
Some patients with systemic juvenile idiopathic arthritis (SJIA) and severe, refractory disease achieved remission through intensive immunosuppressive treatment followed by ... | ALEMTUZUMAB, BUSULFAN, CYCLOPHOSPHAMIDE, CYCLOSPORINE, FLUDARABINE PHOSPHATE, INDOMETHACIN, INFLIXIMAB, METHOTREXATE, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, PREDNISOLONE, RITUXIMAB, THALIDOMIDE | DrugsGivenReaction | CC BY | 33712044 | 19,154,451 | 2021-03-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug resistance'. | Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis.
BACKGROUND
Some patients with systemic juvenile idiopathic arthritis (SJIA) and severe, refractory disease achieved remission through intensive immunosuppressive treatment followed by ... | ACYCLOVIR, ADALIMUMAB, ALEMTUZUMAB, ANAKINRA, BUSULFAN, CANAKINUMAB, CYCLOPHOSPHAMIDE, CYCLOSPORINE, FLUDARABINE PHOSPHATE, HYDROCORTISONE, INDOMETHACIN, INDOMETHACIN SODIUM, INFLIXIMAB, METHOTREXATE, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, PREDNISOLONE, PROPICILLIN POTASSIUM, RITUXIMAB, THALIDOMIDE, TOCILIZUMAB | DrugsGivenReaction | CC BY | 33712044 | 19,050,516 | 2021-03-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ill-defined disorder'. | Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis.
BACKGROUND
Some patients with systemic juvenile idiopathic arthritis (SJIA) and severe, refractory disease achieved remission through intensive immunosuppressive treatment followed by ... | ACYCLOVIR, ADALIMUMAB, ALEMTUZUMAB, ANAKINRA, BUSULFAN, CANAKINUMAB, CYCLOPHOSPHAMIDE, CYCLOSPORINE, FLUDARABINE PHOSPHATE, HYDROCORTISONE, INDOMETHACIN, INDOMETHACIN SODIUM, INFLIXIMAB, METHOTREXATE, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, PREDNISOLONE, PROPICILLIN POTASSIUM, RITUXIMAB, THALIDOMIDE, TOCILIZUMAB | DrugsGivenReaction | CC BY | 33712044 | 19,050,516 | 2021-03-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Impaired quality of life'. | Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis.
BACKGROUND
Some patients with systemic juvenile idiopathic arthritis (SJIA) and severe, refractory disease achieved remission through intensive immunosuppressive treatment followed by ... | ACYCLOVIR, ADALIMUMAB, ALEMTUZUMAB, ANAKINRA, BUSULFAN, CANAKINUMAB, CYCLOPHOSPHAMIDE, CYCLOSPORINE, FLUDARABINE PHOSPHATE, HYDROCORTISONE, INDOMETHACIN, INDOMETHACIN SODIUM, INFLIXIMAB, METHOTREXATE, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, PREDNISOLONE, PROPICILLIN POTASSIUM, RITUXIMAB, THALIDOMIDE, TOCILIZUMAB | DrugsGivenReaction | CC BY | 33712044 | 19,050,516 | 2021-03-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Juvenile idiopathic arthritis'. | Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis.
BACKGROUND
Some patients with systemic juvenile idiopathic arthritis (SJIA) and severe, refractory disease achieved remission through intensive immunosuppressive treatment followed by ... | ACYCLOVIR, ADALIMUMAB, ALEMTUZUMAB, ANAKINRA, BUSULFAN, CANAKINUMAB, CYCLOPHOSPHAMIDE, CYCLOSPORINE, FLUDARABINE PHOSPHATE, HYDROCORTISONE, INDOMETHACIN, INDOMETHACIN SODIUM, INFLIXIMAB, METHOTREXATE, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, PREDNISOLONE, PROPICILLIN POTASSIUM, RITUXIMAB, THALIDOMIDE, TOCILIZUMAB | DrugsGivenReaction | CC BY | 33712044 | 19,050,516 | 2021-03-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lung disorder'. | Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis.
BACKGROUND
Some patients with systemic juvenile idiopathic arthritis (SJIA) and severe, refractory disease achieved remission through intensive immunosuppressive treatment followed by ... | ADALIMUMAB, ALEMTUZUMAB, ANAKINRA, BUSULFAN, CANAKINUMAB, CYCLOPHOSPHAMIDE, CYCLOSPORINE, FLUDARABINE PHOSPHATE, INDOMETHACIN, INFLIXIMAB, METHOTREXATE, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, PREDNISOLONE, RITUXIMAB, THALIDOMIDE, TOCILIZUMAB | DrugsGivenReaction | CC BY | 33712044 | 19,100,589 | 2021-03-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pulmonary function test abnormal'. | Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis.
BACKGROUND
Some patients with systemic juvenile idiopathic arthritis (SJIA) and severe, refractory disease achieved remission through intensive immunosuppressive treatment followed by ... | ACYCLOVIR, ADALIMUMAB, ALEMTUZUMAB, ANAKINRA, BUSULFAN, CANAKINUMAB, CYCLOPHOSPHAMIDE, CYCLOSPORINE, FLUDARABINE PHOSPHATE, HYDROCORTISONE, INDOMETHACIN, INDOMETHACIN SODIUM, INFLIXIMAB, METHOTREXATE, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, PREDNISOLONE, PROPICILLIN POTASSIUM, RITUXIMAB, THALIDOMIDE, TOCILIZUMAB | DrugsGivenReaction | CC BY | 33712044 | 19,050,516 | 2021-03-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Steroid dependence'. | Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis.
BACKGROUND
Some patients with systemic juvenile idiopathic arthritis (SJIA) and severe, refractory disease achieved remission through intensive immunosuppressive treatment followed by ... | ADALIMUMAB, ALEMTUZUMAB, ANAKINRA, BUSULFAN, CANAKINUMAB, CYCLOPHOSPHAMIDE, CYCLOSPORINE, FLUDARABINE PHOSPHATE, INDOMETHACIN, INFLIXIMAB, METHOTREXATE, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, PREDNISOLONE, RITUXIMAB, THALIDOMIDE, TOCILIZUMAB | DrugsGivenReaction | CC BY | 33712044 | 19,100,589 | 2021-03-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Still^s disease'. | Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis.
BACKGROUND
Some patients with systemic juvenile idiopathic arthritis (SJIA) and severe, refractory disease achieved remission through intensive immunosuppressive treatment followed by ... | ACYCLOVIR, ADALIMUMAB, ALEMTUZUMAB, ANAKINRA, BUSULFAN, CANAKINUMAB, CYCLOPHOSPHAMIDE, CYCLOSPORINE, FLUDARABINE PHOSPHATE, HYDROCORTISONE, INDOMETHACIN, INDOMETHACIN SODIUM, INFLIXIMAB, METHOTREXATE, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, PREDNISOLONE, PROPICILLIN POTASSIUM, RITUXIMAB, THALIDOMIDE, TOCILIZUMAB | DrugsGivenReaction | CC BY | 33712044 | 19,050,516 | 2021-03-12 |
What is the weight of the patient? | Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis.
BACKGROUND
Some patients with systemic juvenile idiopathic arthritis (SJIA) and severe, refractory disease achieved remission through intensive immunosuppressive treatment followed by ... | 16 kg. | Weight | CC BY | 33712044 | 18,668,075 | 2021-03-12 |
What was the administration route of drug 'INFLIXIMAB'? | Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis.
BACKGROUND
Some patients with systemic juvenile idiopathic arthritis (SJIA) and severe, refractory disease achieved remission through intensive immunosuppressive treatment followed by ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33712044 | 19,100,589 | 2021-03-12 |
What was the dosage of drug 'HYDROCORTISONE'? | Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis.
BACKGROUND
Some patients with systemic juvenile idiopathic arthritis (SJIA) and severe, refractory disease achieved remission through intensive immunosuppressive treatment followed by ... | 12.5 MG/M2, QD | DrugDosageText | CC BY | 33712044 | 19,102,136 | 2021-03-12 |
What was the dosage of drug 'INDOMETHACIN SODIUM'? | Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis.
BACKGROUND
Some patients with systemic juvenile idiopathic arthritis (SJIA) and severe, refractory disease achieved remission through intensive immunosuppressive treatment followed by ... | 25 MG/M2, QD | DrugDosageText | CC BY | 33712044 | 19,050,516 | 2021-03-12 |
What was the dosage of drug 'METHYLPREDNISOLONE'? | Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis.
BACKGROUND
Some patients with systemic juvenile idiopathic arthritis (SJIA) and severe, refractory disease achieved remission through intensive immunosuppressive treatment followed by ... | PULSE THERAPY | DrugDosageText | CC BY | 33712044 | 19,154,451 | 2021-03-12 |
What was the dosage of drug 'TOCILIZUMAB'? | Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis.
BACKGROUND
Some patients with systemic juvenile idiopathic arthritis (SJIA) and severe, refractory disease achieved remission through intensive immunosuppressive treatment followed by ... | 50 MG, QD | DrugDosageText | CC BY | 33712044 | 19,050,516 | 2021-03-12 |
What was the outcome of reaction 'Actinomycosis'? | Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis.
BACKGROUND
Some patients with systemic juvenile idiopathic arthritis (SJIA) and severe, refractory disease achieved remission through intensive immunosuppressive treatment followed by ... | Recovered | ReactionOutcome | CC BY | 33712044 | 19,154,451 | 2021-03-12 |
What was the outcome of reaction 'Acute graft versus host disease in skin'? | Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis.
BACKGROUND
Some patients with systemic juvenile idiopathic arthritis (SJIA) and severe, refractory disease achieved remission through intensive immunosuppressive treatment followed by ... | Recovering | ReactionOutcome | CC BY | 33712044 | 19,100,589 | 2021-03-12 |
What was the outcome of reaction 'Adrenal insufficiency'? | Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis.
BACKGROUND
Some patients with systemic juvenile idiopathic arthritis (SJIA) and severe, refractory disease achieved remission through intensive immunosuppressive treatment followed by ... | Recovered | ReactionOutcome | CC BY | 33712044 | 19,154,451 | 2021-03-12 |
What was the outcome of reaction 'Aplasia'? | Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis.
BACKGROUND
Some patients with systemic juvenile idiopathic arthritis (SJIA) and severe, refractory disease achieved remission through intensive immunosuppressive treatment followed by ... | Recovered | ReactionOutcome | CC BY | 33712044 | 19,050,516 | 2021-03-12 |
What was the outcome of reaction 'Bronchiolitis'? | Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis.
BACKGROUND
Some patients with systemic juvenile idiopathic arthritis (SJIA) and severe, refractory disease achieved remission through intensive immunosuppressive treatment followed by ... | Recovered | ReactionOutcome | CC BY | 33712044 | 18,668,075 | 2021-03-12 |
What was the outcome of reaction 'Clostridium difficile colitis'? | Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis.
BACKGROUND
Some patients with systemic juvenile idiopathic arthritis (SJIA) and severe, refractory disease achieved remission through intensive immunosuppressive treatment followed by ... | Recovered | ReactionOutcome | CC BY | 33712044 | 19,102,136 | 2021-03-12 |
What was the outcome of reaction 'Graft versus host disease in gastrointestinal tract'? | Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis.
BACKGROUND
Some patients with systemic juvenile idiopathic arthritis (SJIA) and severe, refractory disease achieved remission through intensive immunosuppressive treatment followed by ... | Recovered | ReactionOutcome | CC BY | 33712044 | 20,229,144 | 2021-03-12 |
What was the outcome of reaction 'Growth retardation'? | Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis.
BACKGROUND
Some patients with systemic juvenile idiopathic arthritis (SJIA) and severe, refractory disease achieved remission through intensive immunosuppressive treatment followed by ... | Recovering | ReactionOutcome | CC BY | 33712044 | 19,050,516 | 2021-03-12 |
What was the outcome of reaction 'Infection reactivation'? | Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis.
BACKGROUND
Some patients with systemic juvenile idiopathic arthritis (SJIA) and severe, refractory disease achieved remission through intensive immunosuppressive treatment followed by ... | Recovering | ReactionOutcome | CC BY | 33712044 | 19,102,136 | 2021-03-12 |
What was the outcome of reaction 'Infection'? | Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis.
BACKGROUND
Some patients with systemic juvenile idiopathic arthritis (SJIA) and severe, refractory disease achieved remission through intensive immunosuppressive treatment followed by ... | Recovered | ReactionOutcome | CC BY | 33712044 | 20,229,144 | 2021-03-12 |
What was the outcome of reaction 'Joint effusion'? | Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis.
BACKGROUND
Some patients with systemic juvenile idiopathic arthritis (SJIA) and severe, refractory disease achieved remission through intensive immunosuppressive treatment followed by ... | Recovered | ReactionOutcome | CC BY | 33712044 | 19,050,516 | 2021-03-12 |
What was the outcome of reaction 'Lung disorder'? | Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis.
BACKGROUND
Some patients with systemic juvenile idiopathic arthritis (SJIA) and severe, refractory disease achieved remission through intensive immunosuppressive treatment followed by ... | Recovered | ReactionOutcome | CC BY | 33712044 | 19,100,589 | 2021-03-12 |
What was the outcome of reaction 'Obliterative bronchiolitis'? | Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis.
BACKGROUND
Some patients with systemic juvenile idiopathic arthritis (SJIA) and severe, refractory disease achieved remission through intensive immunosuppressive treatment followed by ... | Recovered | ReactionOutcome | CC BY | 33712044 | 19,102,136 | 2021-03-12 |
What was the outcome of reaction 'Pulmonary function test abnormal'? | Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis.
BACKGROUND
Some patients with systemic juvenile idiopathic arthritis (SJIA) and severe, refractory disease achieved remission through intensive immunosuppressive treatment followed by ... | Recovered | ReactionOutcome | CC BY | 33712044 | 19,050,516 | 2021-03-12 |
What was the outcome of reaction 'Still^s disease'? | Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis.
BACKGROUND
Some patients with systemic juvenile idiopathic arthritis (SJIA) and severe, refractory disease achieved remission through intensive immunosuppressive treatment followed by ... | Recovering | ReactionOutcome | CC BY | 33712044 | 19,050,516 | 2021-03-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy non-responder'. | Latex anaphylaxis in a recipient child during kidney transplant performed in a latex-free environment: case report.
Latex responds for most allergic reactions in children, and repeated exposure to the agent is the main cause of sensitization. We report the case of a child allergic to latex who developed anaphylaxis dur... | NOREPINEPHRINE | DrugsGivenReaction | CC BY-NC-ND | 33712257 | 20,672,373 | 2021 |
What is the weight of the patient? | Latex anaphylaxis in a recipient child during kidney transplant performed in a latex-free environment: case report.
Latex responds for most allergic reactions in children, and repeated exposure to the agent is the main cause of sensitization. We report the case of a child allergic to latex who developed anaphylaxis dur... | 28 kg. | Weight | CC BY-NC-ND | 33712257 | 20,672,373 | 2021 |
What was the dosage of drug 'NOREPINEPHRINE'? | Latex anaphylaxis in a recipient child during kidney transplant performed in a latex-free environment: case report.
Latex responds for most allergic reactions in children, and repeated exposure to the agent is the main cause of sensitization. We report the case of a child allergic to latex who developed anaphylaxis dur... | 0.5 MCG/KG/MIN | DrugDosageText | CC BY-NC-ND | 33712257 | 20,672,373 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Cerebral metastasis of Merkel cell carcinoma following resection with negative margins and adjuvant external beam radiation: a case report.
BACKGROUND
Merkel cell carcinoma (MCC) is a rare and aggressive neuroendocrine tumor of the skin. It is associated with advanced age, ultraviolet (UV) radiation, and Merkel cell po... | HYDROXYCHLOROQUINE | DrugsGivenReaction | CC BY | 33714267 | 20,230,857 | 2021-03-14 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metastases to central nervous system'. | Cerebral metastasis of Merkel cell carcinoma following resection with negative margins and adjuvant external beam radiation: a case report.
BACKGROUND
Merkel cell carcinoma (MCC) is a rare and aggressive neuroendocrine tumor of the skin. It is associated with advanced age, ultraviolet (UV) radiation, and Merkel cell po... | HYDROXYCHLOROQUINE | DrugsGivenReaction | CC BY | 33714267 | 20,211,717 | 2021-03-14 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neuroendocrine carcinoma of the skin'. | Cerebral metastasis of Merkel cell carcinoma following resection with negative margins and adjuvant external beam radiation: a case report.
BACKGROUND
Merkel cell carcinoma (MCC) is a rare and aggressive neuroendocrine tumor of the skin. It is associated with advanced age, ultraviolet (UV) radiation, and Merkel cell po... | HYDROXYCHLOROQUINE | DrugsGivenReaction | CC BY | 33714267 | 20,230,857 | 2021-03-14 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemorrhage in pregnancy'. | Systemic lupus erythematosus and COVID-19 during pregnancy.
Background: The ongoing corona virus disease 2019 (COVID-19) pandemic is having a worldwide impact. Valuable information on the clinical characteristics of COVID-19 in pregnant patients with an autoimmune disease, such as systemic lupus erythematosus (SLE), is... | ASPIRIN, AZATHIOPRINE, ETANERCEPT, HYDROXYCHLOROQUINE, TRIAMCINOLONE ACETONIDE | DrugsGivenReaction | CC BY | 33715506 | 19,766,637 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Normal newborn'. | Systemic lupus erythematosus and COVID-19 during pregnancy.
Background: The ongoing corona virus disease 2019 (COVID-19) pandemic is having a worldwide impact. Valuable information on the clinical characteristics of COVID-19 in pregnant patients with an autoimmune disease, such as systemic lupus erythematosus (SLE), is... | ASPIRIN, AZATHIOPRINE, ETANERCEPT, HYDROXYCHLOROQUINE, TRIAMCINOLONE ACETONIDE | DrugsGivenReaction | CC BY | 33715506 | 19,454,032 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Placenta accreta'. | Systemic lupus erythematosus and COVID-19 during pregnancy.
Background: The ongoing corona virus disease 2019 (COVID-19) pandemic is having a worldwide impact. Valuable information on the clinical characteristics of COVID-19 in pregnant patients with an autoimmune disease, such as systemic lupus erythematosus (SLE), is... | ASPIRIN, AZATHIOPRINE, ETANERCEPT, HYDROXYCHLOROQUINE, TRIAMCINOLONE ACETONIDE | DrugsGivenReaction | CC BY | 33715506 | 19,766,637 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Placenta praevia haemorrhage'. | Systemic lupus erythematosus and COVID-19 during pregnancy.
Background: The ongoing corona virus disease 2019 (COVID-19) pandemic is having a worldwide impact. Valuable information on the clinical characteristics of COVID-19 in pregnant patients with an autoimmune disease, such as systemic lupus erythematosus (SLE), is... | AZATHIOPRINE, ETANERCEPT, HYDROXYCHLOROQUINE, TRIAMCINOLONE ACETONIDE | DrugsGivenReaction | CC BY | 33715506 | 19,817,356 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rebound effect'. | Systemic lupus erythematosus and COVID-19 during pregnancy.
Background: The ongoing corona virus disease 2019 (COVID-19) pandemic is having a worldwide impact. Valuable information on the clinical characteristics of COVID-19 in pregnant patients with an autoimmune disease, such as systemic lupus erythematosus (SLE), is... | ASPIRIN, AZATHIOPRINE, ETANERCEPT, HYDROXYCHLOROQUINE, TRIAMCINOLONE ACETONIDE | DrugsGivenReaction | CC BY | 33715506 | 19,454,032 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Systemic lupus erythematosus'. | Systemic lupus erythematosus and COVID-19 during pregnancy.
Background: The ongoing corona virus disease 2019 (COVID-19) pandemic is having a worldwide impact. Valuable information on the clinical characteristics of COVID-19 in pregnant patients with an autoimmune disease, such as systemic lupus erythematosus (SLE), is... | ASPIRIN, AZATHIOPRINE, ETANERCEPT, HYDROXYCHLOROQUINE, TRIAMCINOLONE ACETONIDE | DrugsGivenReaction | CC BY | 33715506 | 19,454,032 | 2021-06 |
What was the outcome of reaction 'Haemorrhage in pregnancy'? | Systemic lupus erythematosus and COVID-19 during pregnancy.
Background: The ongoing corona virus disease 2019 (COVID-19) pandemic is having a worldwide impact. Valuable information on the clinical characteristics of COVID-19 in pregnant patients with an autoimmune disease, such as systemic lupus erythematosus (SLE), is... | Recovered | ReactionOutcome | CC BY | 33715506 | 19,766,637 | 2021-06 |
What was the outcome of reaction 'Maternal exposure during pregnancy'? | Systemic lupus erythematosus and COVID-19 during pregnancy.
Background: The ongoing corona virus disease 2019 (COVID-19) pandemic is having a worldwide impact. Valuable information on the clinical characteristics of COVID-19 in pregnant patients with an autoimmune disease, such as systemic lupus erythematosus (SLE), is... | Recovered | ReactionOutcome | CC BY | 33715506 | 19,766,637 | 2021-06 |
What was the outcome of reaction 'Placenta accreta'? | Systemic lupus erythematosus and COVID-19 during pregnancy.
Background: The ongoing corona virus disease 2019 (COVID-19) pandemic is having a worldwide impact. Valuable information on the clinical characteristics of COVID-19 in pregnant patients with an autoimmune disease, such as systemic lupus erythematosus (SLE), is... | Recovered | ReactionOutcome | CC BY | 33715506 | 19,766,637 | 2021-06 |
What was the outcome of reaction 'Placenta praevia haemorrhage'? | Systemic lupus erythematosus and COVID-19 during pregnancy.
Background: The ongoing corona virus disease 2019 (COVID-19) pandemic is having a worldwide impact. Valuable information on the clinical characteristics of COVID-19 in pregnant patients with an autoimmune disease, such as systemic lupus erythematosus (SLE), is... | Recovering | ReactionOutcome | CC BY | 33715506 | 19,817,356 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Contraindicated product administered'. | Hypoglycemia during the Concomitant Use of Repaglinide and Clopidogrel in an Elderly Patient with Type 2 Diabetes and Severe Renal Insufficiency.
Hypoglycemia should be avoided when treating patients with diabetes. Repaglinide is an insulin secretagogue with a low hypoglycemic risk because of its rapid- and short-actin... | ASPIRIN, AZELNIDIPINE, CARVEDILOL, CILOSTAZOL, CLOPIDOGREL BISULFATE, EDOXABAN TOSYLATE, FEBUXOSTAT, HYDROCORTISONE, PRAVASTATIN, PROPAFENONE, REPAGLINIDE, TENELIGLIPTIN, VERAPAMIL HYDROCHLORIDE, VONOPRAZAN | DrugsGivenReaction | CC BY-NC-ND | 33716254 | 19,180,403 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Coronary artery dissection'. | Hypoglycemia during the Concomitant Use of Repaglinide and Clopidogrel in an Elderly Patient with Type 2 Diabetes and Severe Renal Insufficiency.
Hypoglycemia should be avoided when treating patients with diabetes. Repaglinide is an insulin secretagogue with a low hypoglycemic risk because of its rapid- and short-actin... | ASPIRIN, AZELNIDIPINE, CARVEDILOL, CILOSTAZOL, CLOPIDOGREL BISULFATE, EDOXABAN TOSYLATE, FEBUXOSTAT, HYDROCORTISONE, PRAVASTATIN SODIUM, PROPAFENONE, REPAGLINIDE, TENELIGLIPTIN, UNSPECIFIED INGREDIENT, VERAPAMIL HYDROCHLORIDE, VONOPRAZAN | DrugsGivenReaction | CC BY-NC-ND | 33716254 | 19,137,817 | 2021 |
What was the administration route of drug 'REPAGLINIDE'? | Hypoglycemia during the Concomitant Use of Repaglinide and Clopidogrel in an Elderly Patient with Type 2 Diabetes and Severe Renal Insufficiency.
Hypoglycemia should be avoided when treating patients with diabetes. Repaglinide is an insulin secretagogue with a low hypoglycemic risk because of its rapid- and short-actin... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33716254 | 19,140,109 | 2021 |
What was the administration route of drug 'TENELIGLIPTIN'? | Hypoglycemia during the Concomitant Use of Repaglinide and Clopidogrel in an Elderly Patient with Type 2 Diabetes and Severe Renal Insufficiency.
Hypoglycemia should be avoided when treating patients with diabetes. Repaglinide is an insulin secretagogue with a low hypoglycemic risk because of its rapid- and short-actin... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33716254 | 19,140,109 | 2021 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.